ArticleNature biomedical engineering2021

A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma.

Bin Sheng Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.